First U.S. Patient Treated Following FDA Approval of Cook Medical’s First-of-Its-Kind Zilver® PTX® Drug-Eluting Peripheral Stent

BLOOMINGTON, Ind.--(BUSINESS WIRE)- Just weeks after the Food and Drug Administration (FDA) approved Cook Medical’s Zilver® PTX® Drug-Eluting Peripheral Stent, OhioHealth Riverside Methodist Hospital in Columbus, Ohio, has treated the first patient with the device as part of Cook’s U.S. commercial launch.